spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 18 Jun 2010
Medicis Announces Organizational Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 18 Jun 2010
Lonnel Coats Appointed President & Chief Executive Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2010
Aquinox Pharmaceuticals Completes US $25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2010
Marshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jun 2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 17 Jun 2010
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 16 Jun 2010
HEALTHPOINT, Ltd. Announces New Vice President, Sales Brad Adams
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jun 2010
New Data Presented from EMBLEM Study for Pipeline Drug Epratuzumab for Patients Suffering from Moderate to Severe Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2010
Relypsa Appoints Claire J. Lockey Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jun 2010
Galera Therapeutics Secures Funding for New Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Jun 2010
POZEN Announces Election of Neal F. Fowler to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2010
Agile Therapeutics Secures $45M in Series B Funding to Progress Lead Contraceptive Patch, AG200-15, Through NDA Filing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2010
Otonomy Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2010
FDA Lifts Full Clinical Hold on Repros' Proellex(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jun 2010
APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jun 2010
Bohai Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2010
Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile Neutropenia Associated With Chemotherapy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Jun 2010
ADVENTRX Grants Exclusive Worldwide Rights to CoFactor Know-How and Data
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jun 2010
Quark Pharmaceuticals Closes $10 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Jun 2010
Human Genome Sciences Announces Submission of Biologics License Application to FDA for BENLYSTA(R) (belimumab)
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2010
NovaDel Pharma Inc. Announces Appointment of Craig Johnson as Senior Vice President, Chief Financial Officer and Secretary
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Jun 2010
Unigene Appoints New CEO, Ashleigh Palmer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2010
Astellas Completes Acquisition of OSI Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2010
Myriad Pharmaceuticals Announces Intent to Focus on Oncology Portfolio
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2010
New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma, Among the Toughest Cancers to Treat
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2010
Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 8 Jun 2010
Astellas Announces Successful Completion of Tender Offer for Shares of OSI
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2010
Biogen Idec Provides Update on CEO Search and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2010
Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2010
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2010
Human Genome Sciences Announces Submission of Marketing Authorization Application to EMA for BENLYSTA(R) (Belimumab)
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2010
Cytheris Closes 12 Million ($15 Million) Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jun 2010
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2010
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2010
Teva Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Jun 2010
Mylan Receives Approval for Generic Version of Neurontin(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Jun 2010
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2010
Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2010
Ascenta Therapeutics Licenses Cancer Drug Candidates to sanofi-aventis
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2010
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 3 Jun 2010
Philips and RXi Pharmaceuticals Sign Agreement to Jointly Research Innovative Image-Guided Therapy Concepts Based on RNAi
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 3 Jun 2010
Bausch & Lomb Acquires Zirgan(R) (Ganciclovir Ophthalmic Gel 0.15%) From Sirion Therapeutics for the Treatment of Herpetic Keratitis
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 3 Jun 2010
Javelin Commences Litigation against Hospira and Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreement and Specific Performance Provision Compels Completion of Merger
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 3 Jun 2010
Biodel Appoints Donald Casey, Jr. to Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 3 Jun 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Jun 2010
Elan Corporation, plc Board Announces CEO Agreement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Pivotal Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2010
Teva Announces Launch of Generic Differin(R)
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 2 Jun 2010
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer's Disease Compounds
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2010
Baxter Names New President of Renal Business and New Chief Financial Officer
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Ikaria(R) Names New Head of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Jun 2010
Orexigen(R) Therapeutics Announces FDA Acceptance of Contrave(R) New Drug Application for the Treatment of Obesity
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2010
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Rigel Pharmaceuticals Names Raul Rodriguez President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Accentia Files Plan of Reorganization
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 May 2010
Xanodyne Announces Planned President & CEO Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2010
NOXXON Pharma AG raises 33 million in Series D Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 May 2010
Repligen Announces FDA and EMA Approval of Re-analysis of Images from Phase 3 Trial of RG1068 for Pancreatic Imaging
Biopharmaceuticals Radiology
 HSMN NewsFeed - 26 May 2010
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2010
Logical Therapeutics Secures $16.9M Series C Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2010
XYTOS Announces the Appointment of John Trotter II, MD as the Company's New Chief Medical Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 26 May 2010
Tesaro, Inc. Secures $60 Million in Start-up Funding
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2010
Elite Pharmaceuticals Announces Acquisition of Generic Hydromorphone Product
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 May 2010
Cleveland BioLabs Adds Regulatory Affairs Expertise to Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2010
NormOxys Secures $17.5 Million Series B Financing to Advance Lead Drug Candidate into Clinical Studies for Two Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 May 2010
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2010
Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 May 2010
EpiCept Corporation Announces Commercial Launch of Ceplene(R) in Germany
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2010
Aastrom Announces Senior Management Appointments
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 20 May 2010
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 19 May 2010
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2010
STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2010
Infinity Announces Senior Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2010
Dr. Henry A. McKinnell Jr., Former Pfizer CEO, Joins Emmaus Medical, Inc. Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2010
NOXXON Pharma AG appoints Dr. Aram Mangasarian as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2010
Teva Reaches Settlement Agreement With AstraZeneca Regarding Generic Entocort(R) EC Capsules
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 May 2010
Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 May 2010
Halozyme Announces Voluntary Recall of HYLENEX(R)
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 May 2010
Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2010
Merck and Cardiome Announce Phase III Study Results Comparing Investigational Compound BRINAVESS(TM) (Vernakalant) Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 May 2010
Teva Announces Tentative Approval of Generic Sensipar(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Opana(R) ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 May 2010
Neotropix Announces Enrollment of Patients in NCI-Sponsored Phase II Clinical Trial for Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 May 2010
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2010
Nuon Therapeutics Names Lee Rauch Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2010
Cobalis Corp. Appoints Martin Marion as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2010
Pfizer Enters Into Agreement With Ergonex Pharma to Acquire Investigational Treatment for Pulmonary Arterial Hypertension
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 May 2010
Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 May 2010
Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2010
Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 10 May 2010
Cipher achieves major milestone with FDA approval for CIP-TRAMADOL ER
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 May 2010
InteKrin Therapeutics Appoints Linda Higgins, PhD as President and Chief Executive Officer. Company Founder Denny Lanfear Named Chairman of the Board.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2010
Adeona Completes a $17.5 Million Corporate Partnership With Meda AB for the Development and Commercialization of Flupirtine for Fibromyalgia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2010
Meda Acquires Exclusive Rights to flupirtine for fibromyalgia, a Potential USD Billion Indication
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
Dicerna Names Douglas Fambrough as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2010
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
Biopharmaceuticals Urology Licensing Distribution
 HSMN NewsFeed - 5 May 2010
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2010
ARIAD Announces Restructuring of Its Ridaforolimus Collaboration with Merck
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 5 May 2010
Merck Acquires Development and Commercialization Rights to Investigational mTOR Inhibitor Ridaforolimus from ARIAD Pharmaceuticals, Inc.
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 4 May 2010
Mylan Receives Approval for Generic Version of Zyban(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 May 2010
AVANIR Pharmaceuticals Announces Hiring of Michael McFadden as Vice President of U.S. Sales and Managed Markets
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 May 2010
PharmAthene Appoints Eric I. Richman as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2010
Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2010
Basilea's Toctino(R) receives marketing authorization in Italy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Apr 2010
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2010
Bavarian Nordic Receives FDA Fast Track Designation for PROSTVAC(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Apr 2010
EyeGate Pharma Establishes Research Collaboration With GlaxoSmithKline to Deliver Medicines Using the EyeGate(R) II Delivery System
Devices Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 29 Apr 2010
Celgene Corporation Announces Senior Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received Approval in the European Union for Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Apr 2010
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in a Key Phase III Clinical Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 28 Apr 2010
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra(R) (lopinavir / ritonavir) for Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 28 Apr 2010
Teva Announces Launch of Generic Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Mylan Receives Approval for Generic Version of Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Lycera Achieves $11 Million Second Tranche in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology
 HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2010
Axelar's Board Strengthened
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Apr 2010
KYTHERA Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2010
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Apr 2010
Amgen Appoints Robert A. Bradway President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 26 Apr 2010
Mylan Begins Marketing First Generic Version of Desoxyn(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Apr 2010
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Marshall Edwards Appoints New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Mirina Corporation Closes Series A-1 Financing Led by Versant Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Biopharmaceuticals Distribution
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!